Table I.
Patients characteristics.
| Patients, total number | 84 |
| Age, mean years (range) | 37 (18–77) |
| Gender | 57 (68%) women |
| BMI, mean (range) | 23,5 (15.6–36.7) |
| IBS SSS | |
| >300 (severe) | 46 (55%) |
| 175 - 300 (moderate) | 34 (40%) |
| 75 - 175 (mild) | 3 (4%) |
| < 75 (no IBS) | 1 (1%) |
| IBS characteristics | |
| Diarrhea predominant | 42 (50%) |
| Constipation predominant | 18 (21%) |
| Constipation/diarrhea Mixed | 24 (29%) |
| Incomplete evacuation | 73 (87%) |
| Defecation at night | 12 (14%) |
| Joint pain | 60 (71%) |
| Fatigue | |
| Fatigue Impact Scale >25 | 71 (85%) |
| FibroFatigue scale >15 | 72 (86%) |
| Allergy | |
| Phadiatop positive* | 27 (32%) |
| Fx5 positive* | 8 (10%) |
| Total sIgE >114 kU/L* | 10 (12%) |
| Malabsorption | |
| Fecal fat >7g/d | 10 of 38 (26%) |
Abbreviation: Number (%) = number of patients (% of total material).
*Standard panels of inhalant (Phadiatop) and food (fx5) allergens (ImmunoCAP, Phadia AB, Uppsala, Sweden).